Daniel J. Haraf

10.9k citations

196 papers · 8.1k indexed · 1 hit paper · h-index 49

Impact in

Otorhinolaryngology top 0.02%
- Head and Neck Cancer Studies
Speech and Hearing top 0.2%
- Dysphagia Assessment and Management

Papers in

Otorhinolaryngology 141
- Head and Neck Cancer Studies 140
Oncology 99
- Cancer Diagnosis and Treatment 31
- Lung Cancer Research Studies 24
- Ear and Head Tumors 21

Co-authors: Everett E. Vokes Ralph R. Weichselbaum Kerstin Stenson Bharat B. Mittal Marcy A. List Ezra E.W. Cohen Merrill S. Kies Joseph K. Salama
Journals: International Journal of Radiation Oncology*Biology*Physics (41 papers)Journal of Clinical Oncology (39 papers)Annals of Oncology (19 papers)Head & Neck (8 papers)Cancer (5 papers)
Partner nations: United States Japan Canada

In The Last Decade

Daniel J. Haraf

188 papers receiving 8.0k citations

Hit Papers

align trajectories log scale

The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy-head and neck scale: A study of utility and validity 1996 · 448 citations

Peers

Countries citing papers authored by Daniel J. Haraf

Since Specialization

Citations

This map shows the geographic impact of Daniel J. Haraf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. Haraf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. Haraf more than expected).

Fields of papers citing papers by Daniel J. Haraf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel J. Haraf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. Haraf. The network helps show where Daniel J. Haraf may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Daniel J. Haraf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel J. Haraf Line = papers co-authored together Daniel J. Haraf links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Early Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus–Associated Oropharyngeal Cancer Clinical Cancer Research ·Ari J. Rosenberg, Evgeny Izumchenko, Aditya Juloori, Rohan Katipally, John Cursio, Noura J. Choudhury, Zhen Gooi, Elizabeth A. Blair, Wei Ru, Viktoria Zvekova, Augustin Vannier, William C. Canup, Frederick S. Jones, Karaka, See Roles Section, Daniel J. Haraf, Everett E. Vokes, Alexander T. Pearson, Nishant Agrawal	2025	1
2	Neoadjuvant HPV16-specific arenavirus-based immunotherapy HB-200 plus chemotherapy followed by response-stratified de-intensification in HPV16+ oropharyngeal cancer: TARGET-HPV. Journal of Clinical Oncology ·Ari J. Rosenberg, Aditya Juloori, Evgeny Izumchenko, John Cursio, Zhen Gooi, Elizabeth A. Blair, Mark W. Lingen, Nicole A. Cipriani, Rifat Hasina, William C. Canup, F. R. Jones, Christopher Plescia, Wendy Vanesa Ricardo Benitez, B. Żółtowski, J.-P. Merlo, Daniel J. Haraf, Alexander T. Pearson, Everett E. Vokes, Nishant Agrawal	2024	4
3	A randomized, double-blind, placebo-controlled phase II study of adjuvant pembrolizumab versus placebo in patients with head and neck squamous cell cancers at high risk for recurrence: The PATHWay study. Journal of Clinical Oncology ·Alexander T. Pearson, Tanguy Y. Seiwert, Roger B. Cohen, Nabil F. Saba, John M. Kaczmar, Mary J. Fidler, James L. Wade, Enrico Castellucci, Theodore Karrison, Rohan Katipally, Aditya Juloori, Ari J. Rosenberg, Daniel J. Haraf, Nishant Agrawal, Everett E. Vokes	2024	4
4	886P Prospective evaluation of dynamic changes of cell-free HPV-DNA (cfHPV-DNA) in locoregional HPV associated (HPV+) oropharyngeal cancer (OPC) treated with neoadjuvant chemotherapy and response-stratified treatment Annals of Oncology ·Ari J. Rosenberg, Evgeny Izumchenko, Aditya Juloori, Zhen Gooi, Alexander T. Pearson, Ann M. Vannier, Elizabeth A. Blair, Herdayanti Herdayanti, А. С. Гинзбург, Mark W. Lingen, Nicole A. Cipriani, Rifat Hasina, Wei Ru, Daniel J. Haraf, Everett E. Vokes, Nishant Agrawal	2023	0
5	Long-Term Results of Induction Chemotherapy Followed by 50 Gy Radiation Therapy Alone for Low-Risk HPV-Positive Oropharynx Cancer International Journal of Radiation OncologyBiologyPhysics ·Dandan Huang, Ari J. Rosenberg, Nishant Agrawal, Alexander T. Pearson, E. W. Weston, Elizabeth A. Blair, 澤田匡人, Filip Houštecký, S.B. Fazliddinov, Rohan Katipally, Daniel J. Haraf, Everett E. Vokes, Aditya Juloori	2023	1
6	Dose and Volume De-Escalation for Human Papillomavirus–Positive Oropharyngeal Cancer is Associated with Favorable Posttreatment Functional Outcomes International Journal of Radiation OncologyBiologyPhysics ·Corey C. Foster, Tanguy Y. Seiwert, Ellen MacCracken, Elizabeth A. Blair, Nishant Agrawal, J.M. Melotek, Louis Portugal, Ryan J. Brisson, Zhen Gooi, Michael T. Spiotto, Everett E. Vokes, Daniel J. Haraf	2020	15
7	Prognostic value of pre-treatment CT texture analysis in combination with change in size of the primary tumor in response to induction chemotherapy for HPV-positive oropharyngeal squamous cell carcinoma Quantitative Imaging in Medicine and Surgery ·Theodoricus de Monasterio, Harold L. Haley, Hui Li, Tanguy Y. Seiwert, Daniel J. Haraf, Lan Li, Maryellen L. Giger, Daniel Thomas Ginat	2019	14
8	OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer Annals of Oncology ·Tanguy Y. Seiwert, Corey C. Foster, Elizabeth A. Blair, Theodore Karrison, Nishant Agrawal, J.M. Melotek, L. Portugal, Ryan J. Brisson, A. Dekker, Sara Kochanny, E. W. Weston, Mark W. Lingen, Victoria Villaflor, Daniel Thomas Ginat, Daniel J. Haraf, Everett E. Vokes	2018	149
9	A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation Annals of Oncology ·Tanguy Y. Seiwert, Thomas E. Darga, Daniel J. Haraf, Elizabeth A. Blair, Kerstin Stenson, Ezra E.W. Cohen, Joseph K. Salama, Victoria Villaflor, M.E. Witt, Mark W. Lingen, Ralph R. Weichselbaum, Everett E. Vokes	2012	23
10	Outcomes of induction chemotherapy followed by concurrent chemoradiation for nasopharyngeal carcinoma Oral Oncology ·Daniel W. Golden, Sonali Rudra, M.E. Witt, T. Nwizu, Ezra E.W. Cohen, Elizabeth A. Blair, Kerstin Stenson, Everett E. Vokes, Daniel J. Haraf	2012	12
11	Epidermal Growth Factor Receptor Inhibitor Gefitinib Added to Chemoradiotherapy in Locally Advanced Head and Neck Cancer Journal of Clinical Oncology ·Ezra E.W. Cohen, Daniel J. Haraf, Rangesh Kunnavakkam, Kerstin Stenson, Elizabeth A. Blair, Bruce Brockstein, Eric P. Lester, Joseph K. Salama, A. Dekker, R. Williams, Mary Ellyn Witt, Tatyana A. Grushko, James J. Dignam, Mark W. Lingen, Olufunmilayo I. Olopade, Everett E. Vokes	2010	64
12	Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer Radiotherapy and Oncology ·Kevin S. Choe, Joseph K. Salama, Kerstin Stenson, Elizabeth A. Blair, Mary Ellyn Witt, Ezra E.W. Cohen, Daniel J. Haraf, Everett E. Vokes	2010	7
13	Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma Annals of Oncology ·Joseph P. Quilatan, Joseph K. Salama, Victoria Pickering, Kerstin Stenson, Ezra E.W. Cohen, M.E. Witt, Daniel J. Haraf, Everett E. Vokes	2008	34
14	Characteristics Associated With Swallowing Changes After Concurrent Chemotherapy and Radiotherapy in Patients With Head and Neck Cancer Archives of Otolaryngology - Head and Neck Surgery ·Joseph K. Salama, Kerstin Stenson, Marcy A. List, Loren K. Mell, Ellen MacCracken, Ezra E.W. Cohen, Elizabeth A. Blair, Everett E. Vokes, Daniel J. Haraf	2008	52
15	C3-01: Phase I Trial of Erlotinib-based Multimodality Therapy for Inoperable Stage III Non-small Cell Lung Cancer Journal of Thoracic Oncology ·Nicholas W. Choong, Ann M. Mauer, Eric P. Lester, Philip C. Hoffman, Daniel J. Haraf, Mark Kozloff, Livia L. Szeto, Everett E. Vokes	2007	1
16	Phase I Study of Concomitant Chemoradiotherapy with Irinotecan, 5-FU., and Hydroxyurea for Patients with Advanced and/or Recurrent Head and Neck Cancer The Cancer Journal ·Joseph K. Salama, Daniel J. Haraf, Kerstin Stenson, Michael T. Milano, Mary Ellyn Witt, Mattia Donadel	2005	10
17	Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary Annals of Oncology ·Athanassios Argiris, Stephanie M. Smith, Kerstin Stenson, Bharat B. Mittal, Harold J. Pelzer, M.S. Kies, Daniel J. Haraf, Everett E. Vokes	2003	39
18	Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer Annals of Oncology ·Julia Oh, Everett E. Vokes, M.S. Kies, Bharat B. Mittal, M.E. Witt, Ralph R. Weichselbaum, Daniel J. Haraf	2003	71
19	Laparoscopic Pelvic Lymph Node Dissection: A Review of 103 Consecutive Cases The Journal of Urology ·Daniel B. Rukstalis, Glenn S. Gerber, Nicholas J. Vogelzang, Daniel J. Haraf, Francis H. Straus, Gerald W. Chodak	1994	42
20	Beam’s-Eye-View Aided Treatment Planning for a Nasopharyngeal Lesion: A Case Report Medical dosimetry ·Franca T. Kuchnir, Laura B. McDonald, L. C. Myrianthopoulos, Daniel J. Haraf	1989	4

About Daniel J. Haraf

Daniel J. Haraf is a scholar working on Otorhinolaryngology, Oncology, Pulmonary and Respiratory Medicine, Surgery and Radiation, having authored 196 papers that have together received 8.1k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (140 papers), Head and Neck Surgical Oncology (62 papers), Cancer Diagnosis and Treatment (31 papers), Lung Cancer Treatments and Mutations (29 papers), Brain Metastases and Treatment (28 papers), Lung Cancer Research Studies (24 papers), Ear and Head Tumors (21 papers) and Oral health in cancer treatment (21 papers). The work is most often cited by research in Otorhinolaryngology (4.8k citations), Speech and Hearing (944 citations), Oncology (3.3k citations), Pulmonary and Respiratory Medicine (3.3k citations) and Surgery (3.4k citations). Daniel J. Haraf has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Everett E. Vokes, Ralph R. Weichselbaum, Kerstin Stenson, Bharat B. Mittal, Marcy A. List, Ezra E.W. Cohen, Merrill S. Kies, Joseph K. Salama, Patricia Mumby and Mary Ellyn Witt. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, Annals of Oncology, Head & Neck and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact